Uses of Bayesian posterior modes in solving complex estimation problems in statistics by Ramsey, Fred L.
AN ABSTRACT OF THE THESIS OF
Lie-Fen Lin for the degree of Doctor ofPhiloso1Dh' in
Statistics presented on March 17, 1992.
Title: Uses of Bayesian Posterior Modesin Solving Complex
Estimation Problems in Statistics
Redacted for Privacy
Abstract approved: r ,--7,1
Fred L.msey
In Bayesian analysis,means are commonly usedto
summarize Bayesian posterior distributions.Problems with
alargenumberof parametersoften require numerical
integrations over many dimensions to obtain means.In this
dissertation, posterior modes with respectto appropriate
measuresareusedtosummarizeBayesianposterior
distributions, using the Newton-Raphsonmethod to locate
modes.Further inference of modes relies onthe normal
approximation,usingasymptoticmultivariatenormal
distributions to approximate posteriordistributions. These
techniquesareappliedtotwostatisticalestimation
problems.
First, Bayesian sequential doseselection procedures
are developed forBioassay problems using Ramsey'sprior
[28].Two adaptive designs forBayesian sequential dose
selection and estimation of the potency curve aregiven.The relative efficiency is used to compare the adaptive
methods with other non-Bayesian methods (Spearman-Karber,
up-and-down, and Robbins-Monro) for estimating the ED50 .
Second, posterior distributions of the order of an
autoregressive (AR) model are determined following Robb's
method (1980).Wolfer's sunspot data is used as an example
to compare the estimating results with FPE, AIC, BIC, and
CICmethods. BothRobb'smethodandthenormal
approximationforestimationoftheorderhavefull
posterior results.Uses of Bayesian Posterior Modes in SolvingComplex






in partial fulfillment of
the requirements for the
degree of
Doctor of Philosophy




Professor of Statist' in charg
Redacted for Privacy
ajor
Head of Department of Statisti
Redacted for Privacy
Dean of Graduate/ school
Date thesis is presented March 17. 1992
Typed by Pao-Pao Liu for Lie-Fen LinACKNOWLEDGEMENTS
I would like to express my most sincere gratitude to
Dr. Fred L. Ramsey, my major professor and thesis advisor,
for his guidance, encouragement and patience duringthe
course of this work.His direct contributions helped in the
completion of the thesis.I also want to thank Dan Brunk,
who provided help with endless patience in the beginning of
doing this thesis.
During my Ph.D. study, many of my friends helpedme in
different ways.I especially wish to express my special
thanks to Mr. So's family, they took care ofmy son and
loved him so much during my research.I would like to thank
Jane, who have helped me more than she knows.
Financial support from the department isgratefully
acknowledged.
I am also indebted to my husband, Pao-Pao,my children
Eddy and Sandra, for giving me warm and bearingup under the
strain. Finally,I want to dedicate this work to my
parents. Theirlove,supportand understanding have
sustained me through all these years.TABLE OF CONTENTS
1INTRODUCTION 1
1.1Introduction 1
1.2The Normal Approximation to a Posterior
Distribution 3
1.2.1Introduction of the Normal
Approximation 3
1.2.2Bayesian Normal Approximation 4
1.2.3Examples 8
1.3Literature Review of the Bayesian Bioassay12
1.4Review of Autoregressive (AR) Time Series 15
1.5Organization of the Dissertation 20
2MOST PROBABLE VALUES (MPV) ESTIMATORS OF THE
POTENCIES IN BAYESIAN BIOASSAY 21
2.1Model of Bayesian Bioassay 21
2.2Modes of the Posterior Distribution 24
2.3Point Estimator of an Effective Dose 28
2.4Bayesian MPV Estimators Inference 30
2.4.1Prior and Posterior Distributions of
an Effective Dose 30
2.4.2Normal Approximation Method for the
Bayesian MPV Estimators Inference 31
3ADAPTIVE DESIGNS FOR ESTIMATING THE POTENCY
CURVE 34
3.1Adaptive Designs 34
3.2Designs for the Adaptive Methods 45
3.3One-step (Non-adaptive) Method 47
3.3.1 Comparisons of Non-adaptive Method
with Adaptive Methods 50
3.4Sperman-nrber (Non-parametric) Method 50
3.4.1 Comparisons of Spearman - Karber Method
with Adaptive Methods 52
3.5Up-and-down (Staircase) Method 52
3.5.1 Comparisons of Up-and-down Method
with Adaptive Methods 56
3.6Robbins-Monro Process 56
3.6.1 Comparisons of Robbins-Monro Process
with Adaptive Methods 61
3.7Comparisons 61
4NORMAL APPROXIMATION METHOD TO ESTIMATE THE
ORDER OF THE AUTOREGRESSIVE (AR) MODEL UNDER
BAYESIAN POINT OF VIEW 70
4.1The Bayesian Approach to Order Estimation
of AR Process 70
4.2Normal Approximation Approach 73
4.3Examples for Wolfer's Sunspot Data 785CONCLUSIONS 85
BIBLIOGRAPHY 88
APPENDIX 92LIST OF FIGURES
Fi Page
1.1The density functions of Beta(3, 11), N(3/14,
.03665), N(2/12, .01736), and N(3/14, .0098)... 6
3.1Determination of x2,1 for s1,1=0 in the first
step




3.3Determination of x30 for s1,1=0, s2,1=0 in the
second step 41
3.4Determination of x3,1 for s1,1=0, s2,1=1 in the
second step 42
3.5Determination of x3,1 for s1,1=1, s2,1=0 in the
second step 42
3.6Determination of x3,1 for s1,1=1, s2,1=1 in the
second step 43
3.7The r.e. of Anm/A16, m=1,2,3, L=6 48
3.8The r.e. of Bnm/B16, m=1,2,3, L=6 48
3.9The r.e. of Anm/A112, m=1,2,3,4,6, L=12 49
3.10 The r.e. of Bnm/B112, m=1,2,3,4,6, L=12 49
3.11 The r.e. of NOnm/N016, m=1,2,3, L=6 51
3.12 The r.e. of B61/N061, A32/N016, A23/N016 51
3.13 The mse of SKNn, n=2,3,6 53
3.14 The r.e. of B61/SKN6, A32/SKN3, A23/SKN2 53
3.15 The mse of UDq, q=001, 035, 075 55
3.16 The r.e. of B61/UD035, B61/UD075 55
3.17 The r.e. of A32/UD035, A32/UD075 57
3.18 The r.e. of A23/UD035, A23/UD075 57
3.19 The mse of RM1Cc, c=.001, .2, .408 593.20
3.21
3.22
The mse of RM2Cc,
The mse of RM3Cc,












3.23 The r.e. of B61/RM6Cc, c=.5, 1 62
3.24 The r.e. of A32/RM3Cc, c=.333, .667 62
3.25 The r.e. of A23/RM2Cc, c=.25, .5454 63
3.26 The r.e. of B61/RM1C2, Anm/RM6C10, Anm/RM1C4,
m=2,3, L=6 63
3.27 The r.e. of B61/N016 65
3.28 The r.e. of N061/N016 65
3.29 The r.e. of SKN6/N016 65
3.30 The r.e. of UD035/N016 65
3.31 The r.e. of RM1C2/N016 65
3.32 The r.e. of XX/N016, XX=B61, N061, SKN6, UD035,
RM1C2 66
3.33 The r.e. of Anm/N016, m=2,3, L=6 67
3.34 The r.e. of SKN2/N016 67
3.35 The r.e. of RM6C10/N016, RM1C4/N016 67
3.36 The r.e. of UD075/N016 67
3.37 The r.e. of XX/N016, XX=A32, A23, SKN2, UD075,
RM6C10, RM1C4 68
4.1Mean corrected of the square root of yearly
averages of sunspots data 1749-1977 84LIST OF TABLES
Table Page
2.1The values of (g1(r(Py ,RP2)), g2(go1)god))
and (H1, H2) for n1 =n2=1 and fi=1,2 29
2.2The values of (g1 (rpo,t(P2)), g2 (rpo,r(p2)))
and (H1, H2) for n1 =n2=2 and 13=1,2 29
2.3The estimated ED50 from means and modes for
n
1=n2=2 and /3=1 and 2 31
3.1The best designs for the adaptive methods (L=6) 47
3.2The best designs for the adaptive methods (L=12)47
3.3The values of c for ni=6,







3, 2, and 1 such that
ED50 are in [0,1] 58
Wolfer's sunspot data
AIC, BIC, CIC, Robb,
method for the order
p 81
4.2The results of analyzing Wolfer's sunspot data
for 1749-1924 from the closed Newton-Cotes (N=3)
and Bayesian normal approximation method for
choosing the maximum order M=12 82
4.3The results of analyzing Wolfer's sunspot data
for 1749-1977 using FPE, AIC, BIC, CIC, and
normal approximation method for the orderp
assumed the maximum order M=15 83Uses of Bayesian Posterior Modes in Solving Complex
Estimation Problems in Statistics
1 INTRODUCTION
1.1 Introduction
In Bayesian analysis,means are commonly used to
summarize Bayesian posterior distributions.For problems
with a large numbers of parameters often require numerical
integrations over many dimensions to obtain means.In this
dissertation, posterior modes with respect to appropriate
measuresareusedtosummarizeBayesianposterior
distributions, using the Newton-Raphson method to locate
modes. Furtherinferenceof modesreliesonnormal
approximation,usingasymptoticmultivariatenormal
distributions to approximate posterior distributions. These
techniques are applied to two statistical problems.These
are the sequential dose selection in bioassay and the
selection of the order of an autoregressive (AR) time series
process.
Inastandard bioassay problem,the experimenter
attempts to test the potency of a stimulus administered at
different levels to different subjects. He chooses M dosage
levels,xl and treats nl subjects at these
levels, respectively.Each subject has a response to a
given dose of drug, either positive (response) or negative
(no response).The experimenter observes the number of2
positive responses and records them as si,...,sm.It is
assumed that each subject has a threshold which the given
dose must equal or exceed to produce a positive response.
However, this threshold may vary from one subject to the
next, and so is treated as a random variable with unknown
distributionP. Pisoftencalledthetolerance
distribution or potency curve.P(x) is the potency of level
x of the stimulus; that is, the tolerance distribution is
defined by the probability P(x)of getting a positive
response to a dosage at level x for all x.The drug dosage
levels may be the actual dosage levels or the logarithms of
these levels.
For Bayesian bioassay, Ramsey (1972) employed Ramsey
prior[28]anddeveloped methodsforestimatingthe
posterior modesofthe posterior densityfunction to
estimate the potencies, Pi's.Thus, potency curve can be
observed by linear interpolation.Two adaptive designs for
sequentially selecting dose from the estimated potencycurve
are developed using posterior modes to estimate the potency
curve in Chapter 3.
Robb(1980)derived the marginal posterior density
function of the order of AR model for estimating the order,
which requires numerical integrations over many dimensions
to obtain the order. The normal approximation,using
multivariate normal density function, will be used to get
around this problem in Chapter 4.3
1.2 The Normal Approximation to a PosteriorDistribution
1.2.1 Introduction of the Normal Approximation
Let y =(y1,..,yn) be a random sample froma distribution
f(yi 8).When the distribution obeys certainregularity
conditions, the likelihood function of 0is approximately
normal and remains approximately normalunder mild one-to-
one transformations of 0 for sufficiently largen (Johnson
1967, 1970).In this case, the logarithm of the likelihood
is approximately quadratic, i.e.,
L(81Y) "(emlY) (0 Om)2 a211 )le ae 2
where Om is the maximum likelihood estimator(mle) of 0.In
general, the quantity
1.82L)L.
n a82 mm (1.2)
is a positive function ofy.The logarithm of a normal






determined by its standard deviationa.Comparison of (1.1)
and(1.3)showsthatthestandarddeviationofthe




The likelihood function of 0is approximatelya normal





The approximated distribution of 0can thus be written as
N(014,-14)1le)
(1.6)
1.2.2 Bayesian Normal Approximation
In Bayesian analysis, deriving themeans and variances
(or covariances)from the posterior distribution of the
parameters is often problematic.In this dissertation, a
normal approximation to the posterior distribution, similar
to that just displayed for the likelihood function,is
developed and illustrated with examples.
Example 1.1Let X be Binomial(10, p).The prior
distribution is Beta(2, 2).Thus the posterior distribution
is Beta(x+2, n+2-x) with density
(pix)pl+X (1 .1)) n+1-x w. r. t. dv (1.7)
where dv is a Lebesgue measure.Suppose x=1; the posterior
distribution is Beta(3, 11) with mean=3/14,variance=.01123,
and mode of this density is 2/12.Use an asymptotic normal






If p*=mean, p ~N(3/14, .03655).If p*=mode, p ~N(2/12,
.01736).The approximate variance evaluated at themean is5
much larger than the true posterior variance comparing with
that at the mode. For a skewed distribution the second
derivative at the mode is more meaningful than themean
because the second derivative at the mean is sometimes small
or close to zero such that the variance is overestimated.
Thereforeusingmodesismeaningfulforaskewed
distribution.
In the next example, the posterior density with respect
to other measure will be displayed to see how the normal
approximation will be changed.
Example 1.2(continuation of example 1.1)
The posterior density function of Beta(x+2, n+2-x)can
be written as
(pix)«p2+X (i_p) n+2-xw.r.t. dv- dv
p(1-p) (1.9)
where dv° is an improper measure.The modes of above
density is 3/14, which is the same as the posteriormean,
andtheapproximatevarianceis.0098. Posterior
distribution of p can be approximated by N(3/14, .0098) when
x=1.A plot of the posterior distribution Beta(3,11) and
above three normal distributions are shown in Fig.1.1.
From Fig.1.1 we can see which normal distribution is
appropriatetousetoapproximatetheposterior
distribution.
As in example 1.1 and example 1.2,the posterior
distribution is appropriate to be approximated by the normal
distribution with mean, which is the mode of the density6
Fig. 1.1 The density functions of Beta(3, 11),








with respect to dv°, and variance evaluated at the mode.
The posterior density function is defined with respect to
some measures specific to the problem under consideration.
Theposteriordistributionoftheparameteristhen
approximated by the multivariate normal distribution.The
approximation procedures for the one-parameter case and the
multi-parameter case are given below.
(A) One-parameter case
(1) Determine posterior density h(0) with respect to an
improper prior;
(2) Find the MODE, Om, of h(0);
(3) Evaluate
[ (7
(32 11 =(2logh(e) lo.




(1) Obtain the posterior density h(81, ,05) with respect










Vom le. ,(i, j=1, ...,s) ;
(1.13)(4) Treat the posterior distribution of 0 as




approximate the posterior distribution of the potencies in
Chapter 2 and used to get around the multiple summations
problem in Chapter 4.
There are more examples in next section to illustrate
the normal approximation method using modes (with respect to
a particular measure) as means of normal distributions.
1.2.3 Examples
The means of the posterior distributions and the modes
of the posterior density functions with respect to improper
measures for some well known distributions are derived in
the following examples.
(A) One parameter case
Example 1.3 Bernoulli. Let X1, Xn be i.i.d.
Bernoulli B(p), and S be the sum of the Xi's.Assume the
prior distribution of p is Beta(a, /9)for 0<p<1.The prior
density function is written as
=r(a) r(a) 10
+(3)
w. r . t. dvo dP (1.15)
P(1
The posterior distribution is Beta(a+S, n +9 -S) with
S+a (S+a)(n+P-S) (P) n+a
Tfar(p)
(n+a+P)2(n+a+P+1)






,Var (I)) 11«p)(S-712)+0;+(n+pP) 3-.9)
9
(1.17)
Example 1.4 Poisson. Let X1, Xn be i.i.d.
Poisson(0) and S be the sum of the Xi's.Assume the prior








and the posterior distribution is Gamma(a+S, n+fl) with
r(e) =
+P (
var(e) '94-c4 nn+P)2 (1.19)
The mode of the density with respect to dv° and the variance
are the same as (1.19).
Example 1.5Exponential.Let X1, Xn be i.i.d.
Exp(A) and S be the sum of the Xi's.Assume the prior
distribution of A is Gamma(a,fl)for A>0.The posterior
distribution is Gamma(a+n, a+0).The mean equals the mode
of the density and the variance of the distribution equals
the approximated variance.
Example 1.6Normal with known a2.Let X1, Xn be
i.i.d. N(0,a2)and consider the estimation of 0.If we
















Since the posterior is a symmetric distribution,the mean
equals the mode and the variance equals the approximate
variance.
Example 1.7Normal with known A.Let X1, Xn be
i.i.d. N(A, 0) and consider the estimation of 0.Assume the
prior density of u0o02/0 is x2 withuo degrees of freedom.
croz+sz The posterior density of ( )/0 isx2with uo+n degrees
of freedom,say u1,where S2= E 2.The posterior
distribution of 0 has
s2+1)02 2(s2+vout) 2
g'(0) °°, var(e)
v1 -2 1 (u1-2)2(u1-4)
The prior density function is
2
-U0a0-uo
it(0)ec e-2-ir 0 2 w.r.t. dvo =e
(1.21)
(1.22)




°,Var (0) lice)2(S2+13°°) 3
(1.23)
Example 1.8 Pareto. Let XV ...,Xnbe i.i.d.
Pareto(0) for X1M0 and X0=1.Assume the prior density of
ln(0)is Uniform(-02,co).The posterior density of 0 is
Gamma(n, n*ln(z)), where zis the geometric mean of (X1,
Xn); that is z =(11 Xe. The mean and varianceof the
posterior distribution of 0 are
1 g()) - 1
'Var(0)
1n(z) n(ln(z) )2 (1.24)
The prior density function of 0 is proportionalto one with11
respect to d0=d0/0.The posterior density with respect to
dv° has mode and variance
M(0) 1 Var (0)Im(e)




Example 1.9 Normal.Let X1, Xn be i.i.d. N(01,02),
with both parameters 01 and 82 unknown.Assume the prior
distributions of 01 and ln(02)are independent and both are











The posterior distribution of uS2/02 is x2 withu degrees of
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The joint prior density function of (01,02) isproportional
to one with respect to dva=d01d02/02.The joint mode of the












Modes are easier to derive thanmeans.When the number
of the observations n is large themeans and the variances
(or covariances) of the distributionsare either close or
equal to the modes and the approximate variances(or
covariances).
1.3 Literature Review of the Bayesian Bioassay
Recently, the Bayesian non-parametric approachhas been
used to estimate the tolerance distributionin the quantal
bioassay.Ayer, et al.(1955), proposed an estimate of P
(potency curve) based on Bernoulli data.Brunk (1970),
Barlow, et al. (1972), and Robertson, etal. (1988) used the
estimate of the isotonic regression to estimatethe potency
curve P.The isotonic regression required the function,P,
to be monotonic where the estimatorsof non-decreasing
densitieswere required to satisfy order restrictions. A
Bayesian approach to estimating Pwas first proposed by
Kraft and Van Eeden (1964).The prior distribution of P is13
the Dirichlet distribution.The main properties of the
Dirichlet distribution are discussed by Wilks(1962) and
Johnson and Kotz (1972).
Ramsey(1972)developed methods for computing the
posterior mode of the joint density function.He used these
modes as estimates of the potencies.Thus the potency curve
can beobserved bylinearinterpolation. Theprior
distribution employed is now knownas the "Ramsey's prior"
[28] and is similar to the Dirichlet process prior developed
by Ferguson (1973).Using Ramsey's estimate, which isa
smoothed version of the isotonic regression estimator,one
may estimate the potency curve at any effective doseq (EDq)
(the effective dose which will cause q percentage of getting
a positive response).
Antoniak (1974) showed that the posterior distribution
of P is a mixture of Dirichlet process distributionsand
derived the Bayes estimator of P for two dosagelevels by
using the squared error loss function, where theBayes
estimators are the means of the posterior distributionof P.
Unfortunately, analysis of this mixture of the Dirichlet
process distributions becomes increasingly intractable when
the number of stimulus levels increases.To simplify the
computationaldifficultyinevaluatingtheseBayes
estimators,Kuo (1988) used linear Bayes estimators to
estimate the potency curve.The disadvantage of this method
is that P may be non-monotonic.14
Disch (1981) derived the marginal posterior density of
P(xk), k=1,2,..,M, and P(x), where xk is the observational
dose and x is the non-observational dose.He computed the
means (Bayes estimators) of the posterior distribution of P
from the marginal posterior densities forany number of
dosage levels.Disch also derived the prior and posterior
distributions of any effective dose assuming Ramsey's prior
for the potency curve.He pointed out that, if there are
too many experimental dose levels or too many observations
per dose level, then the computation for the posterior
cumulative distribution function (c.d.f.) ofEDq becomes
numerically unmanageable.
Asnotedpreviously, themultivariatenormal
distribution will be used to approximate the posterior
distribution ofP. Therefore,the marginal posterior
distribution can be approximated by the normal distribution
and the posterior c.d.f. of EDq can be estimated.The modes
of the posterior distribution of P will be usedas the
estimators to estimate the potency curve (Ramsey (1972)).
The modes of the posterior will converge to the results of
mle's.
Ramsey showed in an example in that an optimal design
one experimental unit is assigned per fix dose level.In
this situation, using Ramsey's method,we can still estimate
the potency curve.Kuo (1983) used the Dirichlet process
prior, in which parameters are distributed uniformlyover15
[0,1], and the squared error loss function to minimize the
risk function, to derive the optimal design.In the optimal
design,the doses were not uniformly spaced,but were
shifted somewhat toward the prior estimated of the ED50 for
two dosage levels.All optimal designs are dependent on p1.
Inthisdissertation,twoadaptivedesignsfor
sequentially choosing design dosesand estimating the
potency curves are developed.Both are sequential methods
using Ramsey's prior and use previous step information in
choosing the new dose level in each step.
1.4 Review of Autoregressive (AR) Time Series
Denote by (Xt)an autoregressive process of finite
order p.In general, an AR process of order p is denoted as
an AR(p) process which is given by
e(B)xt = wt,t=1,2,...
(1.31)
where the wt are white noise with mean zero and finite
variance a2.The stationary conditions for the Oi are very
complicated.One way to get around the difficulty of
insuring stationarity with respect to the conditions given
above is to reparameterize the model in terms of the partial
autocorrelations.If we let denote the kth partial
autocorrelation, i.e. the conditional correlation between Xt
1 p is the prior sample size; itcan be interpreted as
measure thestrength of the belief in the prior guess.If
p is large compared to the experiment sample size, little
weight is given to observations.If (3 is small compared to
the experiment sample size, little weight is given to the
prior guess.16
andXt+kgiven the intervening X's,Xt+i, ... , Xt+k_1 ,then an
AR(p) process has Ivkl <1 for all k5p and ck=0 for allk>p
(Ramsey (1974)).Barndorff-Nielsen and Schou (1973) showed
that there is a one-to-one mapping from(01,...,0p)to
(ci,... , 9p) , and the stationarity conditions in terms of the
Bp's are simply shown as -1<91:<1 for k=1,2,...,p.Let 0N k
denote the kth element of 0 in an AR(p) model.That is, one






j=1, ...,k-1 . (1.32)
Suppose there are n observations Xi,X2,...,Xn froman
AR(p) process, then 0 (B) Xt=wt, t=1,2,...,n.Since wi,...,wn
are i.i.d. N(0,02), the joint density of the n observations
is
n 1




























in terms of T's, we can rewrite (1.33) as




Hp(Op) = Kp(ipp) (1.37)
Let L be the log likelihood function of (1.33) so that
L = lna2 + In Ihrpl





















Unfortunately,the equations of(1.40)are not easily
solved, since the Mj are very complex functions of the B's.
These mle's will be discussed further in Chapter 4.
One approximation to the exact role's of the B's results
from ignoring the term L,involvingI MpI,because Hp(0)
dominates inl m Ifor sufficiently large samples (Box and
Jenkins (1970)).Then,
o*p = (Dp) -1 dp
(1.43)
where dp= (d12,d13,.,d1,p0 i ) ',Dpis the same as Dp without the
first row and first column.These are generally called the
least squares estimates of Bp.The primary interest here is
to estimate the order p of the autoregressive model.
Recently, increasing use has been made of goodness-of-






t(p) are the estimated residuals from a model with p
parametersestimated. Akaike(1969,1970and1974)
advocated a decision theoretic approach and used the future
prediction error (FPE) for the model of order p,
FPE(p)(n+P+1)R 0,=1,2, ...,A6, n -p1P (1.45)
and Akaike's information criterion (AIC),19
AIC(p) = 2P
(1.46)
where we may simply choose the model orderp as the value
that minimizes FPE(p) or AIC(p).Modifications to AIC(p)
have been suggested to improve the large sampleperformance,
since Shibata (1976) showed thatwe do not get a consistent
estimator for the order using AIC(p).These suggestions
relate to replacing 2p/n in (1.46) by pn-11n(n)(Rissenan
1978; Schwarz 1978) or by 2pn-11n(ln(n))(Hannan and Quinn
1979), which will yield consistent estimators fororder.A
simulation study of Lutkepohl(1985) has shown that for
multivariate autoregressions, the modificationof Schwarz
(1978), sometimes called the Bayesian informationcriteria
(BIC),
BIC(p) = In Rp +pinn
n (1.47)
leads most often to correct estimates for modelorder and
has the smallest mean squared predictionerror.
Robb (1980) also used a Bayesian approachto order
estimation of autoregressive time series.The marginal
posterior probability distribution of the order,given the
data,isobtained. The value with maximum posterior
probability is the Bayes estimate of the order withrespect
to a particular loss function.The form of the density
function of the order, given the data, isvery complicated.
As noted previously, the normal approximation method isused
here to simplify complexity.20
1.5Organization of the Dissertation
In Chapter 2, the modes (most probable values (MPV)
estimators) of the posterior distribution, and the point
estimatorsandtheirassociatednormalapproximation
inferences regarding an effective dose in Bayesian bioassay
are presented.In Chapter 3,two adaptive methods for
sequentially choosing fixed doses and estimating the potency
curves are developed and comparisons with non-adaptive, up-
and-down, Robbins-Monro, and Spearman-Kdrber methods for
estimating the ED50 are given.In Chapter 4, the marginal
posteriordensityfunctionoftheorderofthe
autoregressive timeseriesisdiscussed. Thenormal
approximation method applied tosimplify the multiple
integrations required to compute their densities is given.
In Chapter5,the conclusions of the dissertation are
discussed.21
2MOST PROBABLE VALUES (MPV) ESTIMATORS
OF THE POTENCIES IN BAYESIAN BIOASSAY
2.1 Model of Bayesian Bioassay
The function P(x)is assumed to be an increasing
function in x.For observational doses xi(i=1, M)
it is assumed that x1<x2<...<xm.The random variable si has
a binomial distribution with parameters(ni,P(x1)).We
assume that si, sm are independent and denote P(x1) as
Pi.The joint likelihood for Pl,..., Pmis
L (.91, ...,Stet
IP1, ... ,Pm)ac 1-1 Pis' (1-Pi) .
1-1 (2.1)
Prior Distribution
The prior chosen is Ramsey's prior [28] (Ramsey (1972))
which isa Dirichlet process prior with parameter alp
(i=1,2,..., M+1) (see also Ferguson (1973)).Let a1 be non-
negative constants and the summation of a1 (1= 1,2,..., M+1)
be unity.Let the function Q(x) be a prior guess at the
unknown potency curve P(x) and denote Q(x1) as Q1.We can
select
al =
ai = Qi Qi-1 (i=2, 3,, )4
am.1= 1 QM
(2.2)
For any observational doses xi<...<xm, the successive
differencesinpotencyhaveanorderedDirichlet
distribution with the density functions randr° with22
respect to the Lebesgue measure,dv,and an improper


















and O<P7 <...<Pm5_1.Note that P0=Q0=0 and Pm+1=Qm+1=1.
For any non-observational dose x betweenxk and xk+i, we
assume an ordered Dirichlet prior over (P1,
Pk+1,
9M+1)
..., Pm) with parameters (91, ..., 9, 9*,
and 0.5_1D15_....PkP(x).5_Pk+1...Pm1 where
Vi = PQ1 = alP
Bpi = P (QiQi_1) =aiP(1=2, ...,k,k +2,.. A)
(Pm+1= 13(1 QM)= am+113
q)* = 13 [Q(x) Qk]
= P [Qk+3. Q(x) ]
(p* + 0** =ak+iP
E= P
Then the prior is proportional to
M+1






Note that P0=0 and P14+1=1.The marginal distribution of P(x)
is a Beta distribution,
P(x) Q(x) *$, (l-Q(x)) *# ).
Thus, prior mode = prior mean = Q(x).The constant is
non-negative and can be used to specify the degree of
smoothing in the posterior estimate.For #=0 and #-00, the
posterior estimators are the isotonic regressor and Q,
respectively.Also,flcan be interpreted as a measure of
the strength of belief in the prior guess Q.
Posterior Distribution
The joint density of the posterior distribution for the
observational doses is proportional to
M+1





[ (1-Pi) [H aiP] w.r. t. dvo
i=1 i=1 (2.7B)
If there is a dose x between xk and xk+i, the joint density
of the posterior distribution is proportional to
M+1






w.r . t .dP(x)ildPi (2.8A)M+1










2.2 Modes of the Posterior Distribution
For the potency curve, P(x), both the jointmodes and
meansofthe posterior density may be consideredas
estimators .For calculating the means, we need to derive
the marginal posterior density functions ofPi from (2.7A)
(Disch, 1981).In what follows,we will concentrate on the
joint posterior modesas estimators, and we will refer to
them as"most probable value"(MPV)estimators. Let
g(P1,...,Pm)be expression(2.7B),which is the joint
density function.Setting the partial derivatives of the
logarithm of g(P1,..., Pm) with respectto the potencies to
zero, we have the expressions
Sin.-si aiP ai#141 logg(P1,(P1,...Pm) 1 + api Pi 3. -PiPi
(1 =1, 2,..., (2.9)
where Po=0, and Pm+1=1.Let f =(f1, fm),
P=(P1, ..., Pm),21=(H1, anddf=[dfu]for
i,j=1,...,M, where=a sini-siaip ai+iP (P) logg Pi1-PiPi -pi-1Pi+1-Pi














aPi aPi-1 (Pi-Pi-1) 2













We can solve the M equations in (2.10) for modesHby using
the Newton-Raphson iteration process with
Pr+iPrf (Pr) dri (Pr) (2.15)
for the (r+l)th iteration P"1 until the sequence converges
toH.These modes are unique since (2.7B)is a concave
function.In the Newton-Raphson method in the bioassay
problem, the solutions of modes are very sensitive to the
initial valuesPo. Theisotonic regression estimator
introduced by Ayeretal.(1955),Brunk(1970),and
Robertson (1988), will be used as the initial values of Po.
The simple form of this estimator is
s s
P(x) = min max (Esj/En)i ilsOf 1lij =r .1'-r (2.16)
FortheDirichletdistribution,themeansofthe26
distribution equal the modes of the density e with respect
to measure dv °, which is a property of the Dirichlet prior
distribution.It will not be so in the posterior.In the
following example, we will see how different the modesare
from the means.
Example 2.1 Consider the dose levels M=2 and the prior
guess Q(x)=x for 0 .x1.Assume the observational doses are
x1=1/3 and x2=2/3 and get ai=1/3 for i=1, 2, and 3.Then the
prior density function is proportional to
1 1 1
P13 (P2-P1)3 (1-P2) 3 w. r. t. otO
(2.17)
and the posterior density function is
S 4122-32
g(Pli P2) P13(1-P1)n1-51(P2-P1) 3 P22 (1-132) 3







Let B(a,b) be a Beta distribution with parametersa and b.
The posterior means of the posterior distribution, of P1 and
P2,with respect to dvadPi for i=1,2 should be
s2
8T1,1) = cE{(-1) I CgAB(i+n2-s2+1,
* B(s+1+1,i+ni-si+n2-s2+ } 3 3
th-s,
X(P2) = CE {(-1)-itnisiBu+s1+4,
k 1 j =0
* B(j+si+s,++1,n2-s2+1)}
(2.20)27





Define gl and g2 as
s +. 2
( )=alogg 13n1-s1
8133. P1 1-P1 P2 -pi.
I. 1+n -s 3 22 (pi, P2) = f_o_gs 3 s2-
aP2 P2-P1 P2 1-P2
(2.21)
(2.22)
The modes of P1 and P2 will be suchthat g1 and g2 equal
zero.The forms of the modesare not explicit but the forms
ofthe means are known (2.20).In order to evaluate the
differences between the modes and themeans we replace the




In the following two examples, thedifference between the
modes and the means are examined.
The values of g1 and g2 are evaluated at r(P0and r(P2)
from (2.19)for the cases both ofn1=n2=1,)3=1,2 and of
n1=n2=2 ,)9=1,2(see Table 2.1 and 2.2).In Table 2.1,
n1=n2=1, /3=1,2 and the absolute values ofgi (r(P1), g'(P2)) and
g2(g1P1),g'(P2))are less than .00005 if(si,s2)= (0,0),
(1,0),and (1,1).For (s1,s2) = (0,1),the absolute values28
of gl and g2 are a greater than 0.2.In Table 2.2, n1 =n2=2,
0=1,2and the absolute values ofg1(r(P1),r(P2))and
g2(r(P1),r(P2))are less than .0002 if(s1,s2)= (0,0),
(1,0), (2,0), (2,1), and (2,2).For (si,s2) = (0,1), (0,2),
(1,1), and (1,2), the absolute values of functionsg1 and g2
are greater than 0.15.
From Table 2.1 and Table 2.2 we see that the means are
equal to the modes (g1.0) when s1 >s2 and the means are not
equal to the modes (g1 #0) when s1<s2.We can also observe
that H1 5r(P1) and H2r(P2) for s1 5s2, where Hi is the mode of
Pi.In general, for any M dosage levels, if there exists
any si5si.o, then H1 5..r(P1) and Holr(Pm).The joint modes
at the peak of the posterior distribution will converge to
the mle's.The joint modes of the posterior density will be
used to estimate the actual potency curve.
2.3 Point Estimator of an Effective Dose
Ramsey (1972) developed a method for computing the mode
which is used to estimate the true potency curve. His
estimator can estimate any effective dose.Let Hi be the
mode of ith observational dose.The estimator H(x), of








where Q0=H0=0 and Qm+1=Hm+1=1.When estimating the effective
dose EDq, the experimenter observes which dose xh yields
H(xh)=q.In other words, if the observational dose xi is29
Table 2.1 The values of (gi(r(Pl),'(P2)),g2ray,r(p2) ) )
and(H1, H2)for n1 =n2=1 and /3=1,2



































I A :evaluated at (r(P1),r(P2) ).
Table 2.2The values of (g1('(P1)Rp2) )g2(rp1),Rp2) ) )
and (H1, HO for n1 =n2=2 and /3=1,2


















'A': evaluated at (r(P1), r(P2)).30
suchthatH1 =q,thentheestimatedEDqisdosex1.
Otherwise, we can determine a pair of (xi,xi+i) which will
satisfy Hi<q<Hi.o.We have the equation
Q(xh) Q(xh)Qi
H(xh) (2.25)
in which H(xh)=q.Therefore, we have
Q(xh) = 0- + (1-111
1 1/141111(Q1+1Qi) (2.26)
Once we obtain Q(xh), we can find the estimated EDq which is
xh from Q-1.
Example 2.2 (continuation of example 2.1)
For n
1=n2=1 and 19=1,2,we know that the estimated
potency curve by using means and modes are different for
(s1,s2)=(0,1) but the estimated ED50 (=0.5) are the same in
both cases.In this case, both means and modes give the
same estimated ED50.Similarly, for n1 =n2=2 and fl=1, 2, the
estimated means and modes are different for (s1,s2)e
{(0,1),(0,2),(1,1),(1,2)).Both means and modes have the
same estimated ED50=0.5 for (s1,s2)=(0,2) and (1,1).For
(s1 ,s2)=(0,1) and (1,2), the estimated ED50 formeans and
modes are displayed in Table 2.3.
2.4 Bayesian MPV Estimators Inference
2.4.1 Prior and Posterior Distributions of an Effective
Dose
In section 2.3, we determined the point estimate of an
effective dose.Disch (1981) derived a prior c.d.f. of the31
Table 2.3 The estimated ED50 frommeans and modes forn1=n2=2
and /3 =1 and 2




1 (0,1) .66777 .65456
(1, 2) .33223 .34544
2 (0,1) .63846 .63240
(1, 2) .36153 .36760
effective dose q (EDq) which isan incomplete Beta(1-q;b,a),
a=pQ(x) and b=P(1-Q(x)). The posteriorc.d.f. (derived from
the marginal posterior distributionof P(x)) of the EDq is
a linear combination of the incomplete Beta distribution
functions. Computationofthemarginalposterior
distribution of P(x)involves multiple summations which
cause complexity of computation.The normal approximation
method can be used here, so the posteriordistribution of
the potencies can be approximated bythe multivariate normal
distribution and the marginal posteriordistribution of P(x)
can be approximated by an univariate normal distribution.
2.4.2 Normal Approximation Method for theBayesian MPV
Estimators Inference
The posterior density function is proportionalto
M M+1




The modes H=(H/,...,EWcan be calculated by using the




So,the approximate jointposterior distributionofPi
(i=1,...,M) is
P MVN( H,VH) (2.29)
and the approximate marginalposterior distributionof Pi
(i=1, M) for the observational dose xi is N(H1, V(Hi)),
where V(Hi)=[VH]fl.
For any non-observational dose x between xi andxi+i, we
have (Ramsey (1972))
Q1+1- Q(x) Q(x) -Qi
P(x) P(x)Pi (2.30)
(xi <x <xi.1) .
From (2.30), we can find









Therefore, the marginal posterior distribution of thenon-




Var(P(x)) = (1t) 2Val- (Pi) +t2Va. r(Pi+i)
+ 2 t (1t) Cov(Pi, P1+1) (2.34)and, the approximated posterior c.d.f. ofEDq is
1-E. f(y)dy = 10(q- r(P(x)))
slVar (P (x)) )
33
(2.35)
where 0 is a c.d.f. of standard normal distribution.If the
estimated EDq is the observational dosexi, f(y) will be the
density function of N(Hi, V(Hi)).However, f(y) will be the
density of (2.33)if the estimated EDq is betweenxi and
xi+1'
T1,
Example 2.3We want to estimate the first quartile,
of the distribution of the EDq. If there is an
observational dose such that FEDq(xi)=Pr(EDq5.xi)=.25,we have
Ti=xi.If not, we determine the pair of observationaldoses
(xi,xi+1)such thatFEDg (Xi) ) <. 25<FEDg (Xj+1 ) ,i.e. xi<Ti<xi+i and
F(TO = 1(D(q- EDq
VVar (P(71))
(2.36)





where '(P (T1)) and Var(P(TO)are described in (2.34) and
then solve for T1.34
3 ADAPTIVE DESIGNS FOR ESTIMATING THEPOTENCY CURVE
3.1 Adaptive Designs
The adaptive designs developed hereare for sequential
selection of the test doses forestimating the potency
curve.Then use the estimated potencycurve to obtain the
final ED50 estimate in the laststep.
The prior is assumed to be theRamsey's prior [28]
(Ramsey (1972))in this Bayesian analysis.The adaptive
methodissequential,thepriormodalfunctionQ(x)
incorporating into a non-informative function.We assume
Q(x)is uniform over[0,1]in the first step of the
analysis.If there are L (=m*n)experimental subjects
availablefortestingatfixeddoseschosenbythe
experimenter, Ramsey (1972) showed thatthe best design (in
the sense of estimating the ED50 bycomparing bias, standard
deviation, and the meansquare error) used one subject per
dose.In this adaptive method, we will performn steps and
assign one subject per dose tom doses.In the first step,
we choose doses uniformly for dose i/(m+1), i=1,..,m.Then,
the estimated potencycurve is used as the prior modal
function to find the new dosage levelsfor the next step.
Algorithms for evaluating two adaptivedesigns using (A)
full information and (B) reduced informationfollow.Also
an example for L=6, m=1 and n=6,is given to illustrate
these two adaptive designs.(A) Full Information Method




We choose 0=2 for all n steps and use m doses in each step.
In the last step we use L (=m*n)doses and full prior
distribution, incorporating all L parameters, to estimate




Selected dosage levels:xLi= i /(m +l), i=1,...,m.
m+1
Prior ..: II (P(xl,i) -P(xi,i_l) )441,where
p1=2, al= n74-11
,
Likelihood ac P (xi)8(1-P(2ci,i) )i-s,.i
(3.2)
(3.3)
Posterior c< Likelihood * Prior.Evaluate the new m doses
from the posterior modal function, 111(x), such
that x2,i=1.11-1(i/(m+1)), i=1,...,m.
Step k (k=2,...,n-1) :
Selected dosages (X1,...,X0, where
"1= (x1.1,.xiadixm





)l 'SIkin x 2by the first column, xj,i, to (xt,st),
where X= (xi, ,xkm),Ey=(sko, i sk,m) 131=-"(s1, " I skm)
km
Likelihoodcc f P(xi) si (1-P(xi) )1 -si
i-3.
Jart+1




Pk=2, ai=xi-x1_1, i=1,...,m+1. (3.5)
Posterior c< Likelihood * Prior.Evaluate the new m doses
from the posterior modal function Hk(x)such that
xk+i,i=Hk-1(i/(m+1)), i=1,...,m.
Step n :










by the first column, xbi, to (xt,st),where
X--(x1,...,x), 8=(si,...,s1.).





Posterior oc Likelihood * Prior.The estimated potency
curve Hn(x) is the estimated posterior modal function.
(3.6)
(3.7)37
(B) Reduced Information Method
The prior is proportional to (3.1), whereai=1/(m+1),
i=1,...,m+1.We begin by choosing /3=2 and then, foreach
step, increase Q by the incrementm.The posterior modes
are computed in each step and the posterior modalfunction
Hk(x) is adjusted from the previous stepmodal function
Hk_1(x).The new m doses are chosen from the adjustedmodal
function Hk(x).The algorithm is shown below.
Step 1 :
Q(x)=x,
Selected dosage levels:xL= i /(m +l), i=1,...,m.
m+1









Posterior c< Likelihood * Prior.Evaluate the new m doses
from the estimated posterior modal functionH1(x) such
that x2, i=1-11-1( i/ (m+1) ),i=1, . . . ,m.
Step k (k=2,...,n-1) :
Selected dosages Xk=(xko,...,xk,m)
m
Likelihood cc fl P(x.k,i) S" (1--P(xk,i))1-sk1
m+1












[ (i +1) Hk(Xk, i) 1Hic(XJ, i+1))
+ (111+1) (lik(XL i+3.) lik(XL i) ) Hki. (X)r
for Xk,15 X SXk.ifi,i=1,2,...,m-1
[(m+1)Hk(X.kad m] + (Ri+1) (1Hk (Xk,m) )Hk_i (X) ,
for xk,msx s 1
whereHic_1(xk,i)=i/(m+1), i=1,...,m.The new m doses are





Likelihood oc IIP (x,i)84"(1-P (x, i))1-sn'i i-i
m..1.











for xn,is x sxn,i+1,i=1,2,...,m-1
[(m+1) H (xn,m) -m)+(m+1) (1-Hn(xn,,))Hn_1(x),
for xn,msx s 1 (3.15)
.. ,m.The estimated potency where H11-1(x0=i/(m+1),i=1,.39
curve function Hn(x) is the estimated posterior modal
function.
Example 3.1Let L=6, m=1 and n=6.The procedures for




so, Prior .2c P(1/2)[1-P(1/2)]
Likelihood 04P(1/2) 81.1(1-
PosteriorccP(1/2) 81.1+1(1-P(1/2))




















Fig. 3.1 Determination ofx21


















After the first step the procedures diverge.They are
illustrated separately.For ease of explanation, design B
is discussed first.
Fig. 3.2Determination of x2,1
















1(,1is selected from the (k-1) th step, pk=1+k,
a.=1/2, i=1,2.So,
1+k 1+k
Priore< P (xk,i)2 (1_p(xk,1) )2
Likelihoodoc P(xk,i)(1-P(xk,1) )1-8k>_
1+k+sk.i
Poster ior<P(xk,i) (1P(Xic,i) )
























s21=0:the fixed doses are x11=1/2, x2,1=5/8, and
H2(x20)=3/8.112(x) can be expressed as (3.12),






























(2) s11=0 s21=1 : the fixed doses are x11=1/2, x21=5/8, and
5/8.H2(x) can be expressed as (3.12), H1 (x1,1) =1/3112 (X2,1)
so H ( ) 2*H2 (x2,1)*Hi(x1,1)=2 (5/8) (1/3)=5/12. Since
H2(x3,1)=1/2, H2(x1,1)<H2(x3,1)<H2(x2,1), (see Fig. 3.4)X2.1 -X1.1* ( .5-H ())=x3,1=0.55
x3.1x11+H2 (X2.1) H2 (Xi,i)
2 X1,1
Fig. 3.4 Determination of x31






















(3) s10=1 s2,1=0: the fixed doses are x1,1=1/2, x2,1=3/8, and
ili(xi,i)=2/3/H2(X2,1)=3/8*H2(x)can be expressed as (3.12),
soH ( =[2*H2(x2,1)-1 ]-1-2*(1-H2(x2,1 )*Hi (x1,1)=0.58333.
Since H2(x3,1)=1/2, H2(x2,1)<H (x3,1)<H2(xi,i),(see. Fig. 3.5)
L1X2,1
*5-112 (X2,1) ) X3,1=0 45 X3,1 = X2'1+H2(X1X,1) H2 (X2,1)
(3.30)
Fig. 3.5 Determination ofx3,1





















(4) s1,1=1 s2,1=1 : the fixed doses are x1,1=1/2, x2,1=3/8,and
H1 (x1 1)=2/3, H2(x2,1)=5/8.H2 (x) can be expressed as (3.12),
so H2(XL1 )=[2*H2(x2,1)-1] +2*(1-H2(x2,1))*H/(x0=0.75.Since
H2(x3,1)=1/2, O<H2(x3,1)<H2(x2,1),(see Fig. 3.6).
x3,1 1/2
X2,1 H2 (X2,1)
x 3,1 =0 3
Fig. 3.6 Determination of x3,1























This continues from k=2 to k=6 and the final selected dose
in the last step is the final ED50 estimate.The six




Let the fixed doses X=(x1,1,fxko), where x
1(0is selected
from the (k-1)th step, and the corresponding responses are
.Sort X in ascending order, such that











Posterior .11 P (xi) si (1-P (xi) )1-si -r-rn (p(x,) -p(xi_o )2ai
i1 1=1 (3.34)
There is no explicit form of H(x1).The Newton-Raphson
method is used to calculate H(x).
(1)s11 =0 s2,1=0 :the fixed doses are x1,1=1/2, x2,1=5/8.
So,7L=(x1,x2)=(1/2, 5/8) and El= (si, s2) = (0,0) ,/31=2,p2=2,
ai=1/2,a2=1/8,anda3=3/8. WehaveH2(X1)=0 . 25and




3'1=X2-1+H2 (Xi) -H2 (Xi_i)
* ( . 5-H2 (Xi_i) )
(3.35)
From (3.35), x3,1 can be calculatedas .71429.
(2) sl=0 s2,1=1 :the fixed doses are x11=1/2, x2,1=5/8.
So, X =(x1, x2)=(1/2,5/8) and S=(si,s2)=(0,1),13 =2,132=2,
ai=1/2,a2=1/8,anda3=3/8.We haveH2(x1)=0.39522and
H2(x2)=.68038.From(3.35),x3,1 can be calculated as .54593.
(3) s1=1 s2,1=0 :the fixed doses are x1,1=1/2, x2,1=3/8.
So, X =(x1, x2)=(3/8, 1/2) and 8=(si,s2)=(0,1),pi=2,132=2,
a1=3/8,a2=1/8,and a3=1/2.We haveH2(x1)=0.31962and
H2(x2)=.60478. From (3.35), x3,1 can be calculatedas .45407.
(4)sio=1 s21=1 :the fixed doses are x11=1/2, x2,1=3/8.
So, X =(x1, x2)=(3/8,1/2)and 121=(s1,s2)=(1,1),/31=2,132=2,45
a1=3/8,a2=1/8,and a3=1/2. We have H2(x1) =O. 65625 and
H2(x2)=.75000From (3.35), x3,1 can be calculatedas .28571.
This continues from k=2 to k=6 andthe final selected dose
is the final ED50 estimate.The six selected doses and the
final ED50 estimate are shown inthe Appendix.
Anexampleofcomputingtheexactlysampling
distribution of the final ED50 estimatewill be given in
nextsection to evaluate the efficiencyof different
combinations of m and n in estimatingthe true ED50.
3.2 Designs for the Adaptive Methods
Assume that the actual potency curve is P(x)=xd,d>0,
The goal of this section is to constructthe best
design for estimating the true ED50 ofa given L subjects.
For L=6, four experimental designsare examined.With
the possible {n;m} arrangements,we consider {6;1), {3;2),
{2;3), and {1;6) experiments wheren is the number of steps
and m is the number of doses.Each dose is assigned to one
subject in each step.There are 64 possible outcomes for
all experiments.
For L=12, six experimental designsare examined.With
the possible {n;m) arrangements,we consider {12;1), {6;2 },
{4;3),{3;4),{2;6), and {1;12) experiments.There are
212=4096 possible outcomesfor all experiments.
The values of d are chosen from [ .001,20].For any d,
calculate exactly sampling distributionfor the final ED50
estimate. The relative efficiency(r.e.) is used to compare46
(n;m) designs with (1;L) design in adaptive method A (full
information)and method B(reduced information). For
convenience, we will adopt the following to describe the
experiments:
Anm :adaptive method A for n steps and m doses per
step.(fl=2 for all steps);
Bnm :adaptive method B for n steps and m doses per
step. (31=2, Pi=pi.i+m for ith step, i=2,...,n).
AIL and B1L are equivalent designs.The selected doses
x,,...,x6 and estimated ED50, L=6, for Anm and Bnm designs
are shown in the Appendix.The r.e. of design Y relative to
design X is defined as
r.e. (Y/A) mse(X)100%
mse(Y) (3.36)
For convenience the notation "Y/X" is used for r.e.(Y/X).
Note that the scales of all figures for d in this chapter
are logarithmic.The notation d-1 will be used for
de(.5,4); otherwise, d#1 will be used.
The best designs of adaptive methods for L=6 and 12
are shown in Table 3.1, 3.2, respectively (see Fig. 3.7
3.10).From above computation, we see that design B, with
one dose (close to the prior ED50) per step, is the best
(highest r.e.)for estimation of the true ED50 if the
initial uniform prior modal function Q(x)is close to the
true potency curves (d-1).If the prior guess is bad (prior
ED50 is not close to the true ED50 for d4.1), design A for
man appears the best.
Assuming P(x)=xd, d>0, Ox5.1 and L=6 (L=m*n), there are47
Table 3.1The best designs for the adaptive methods
(L=6)
Method A Method B Both A and B
d.-1 A61 B61 B61
d+1 A23, A32 B16 A23, A32
Table 3.2The best designs for the adaptive methods
(L=12)
Method A Method B Both A and B
d-1 A121 B121 B121
d+1 A34, A43 B112 A34, A43
four methods which will be described in the following
sections for estimating the ED50: (A) one-step method(non-
adaptive), (B) Spearman-Karber method (non-parametric)(27]
(Finney (1964)), (C) up-and-down (staircase)method (Dixon
(1948, 1965), Little (1974)), and (D) Robbins-Monroprocess
(Cochran and Davis (1965)).
3.3 One-step (Non-adaptive) Method
Thisisaone-step methodofBayesian bioassay.
Bayesian posterior modes for /3 =2, ai=1/(m+1), i=1,...,m,are
used to estimate the potency curve.We assign n subjects
per dose to m equally spaced doses (x1=i/(m+1), i=1,...,m)
and find the estimated ED50.For convenience ,we will
adopt the following to describe the experiments:
NOnm :non-adaptive method assigning n subjects to
each m doses.(Q =2, one-step).
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for NO16, NO23, NO32, and NO61 are shown in the Appendix.
The best design of the non-adaptive method isNO61 for
d-+1; otherwise, NO16 is the best (see Fig. 3.11).The NO61
design will be compared with other methodsfor estimating
ED50 for d-a in section 3.7; otherwise, NO16 willbe used.
3.3.1 Comparisons of Non-adaptive Method with Adaptive
Methods
NO61 will be compared with B61 for d-l.A32 and A23
will be compared with NO16 for d+1.Comparing the r.e.,
NO61is more efficient than the B61 designford-41;
otherwise, A23 and A32 dominate the NO16 design(see Fig.
3.12).
3.4 Spearman-Kirber (Non-parametric) Method
The Spearman-Kdrber estimatorisanon-parametric
estimator of the ED50.If the levels are ordered such that
xi<...<xm, this estimator is defined by
mx-.1(Pi +1-P1) (xi+x1 +1)
2
(3.37)
provided that P1=0 and Pm=1, where Pi=si/ni,ni is the number
of the observations and si is the number of the positive
responses at dose xi,i=1,...,m.If P1>0, then an extra
level is added below x1, where noresponses are assumed to
occur.Similarly, if Pm<1, an extra level is addedabove xm,
where responses are assumed tooccur. The levels are
assumed to be equally spaced and nin, i=1,...,m.So, we
will have n1 =6, 3, and 2 possible experimentsand the testL
U
C.
























dosage levels x1=i/(m+1), i=1,..,m.For convenience, we
will adopt the following to describe the experiments:
SKNn :Spearman-Kdrber methods for ni=ne(2, 3, 6).
The fixed doses and the estimated ED50 of allpossible
outcomes for SKN6, SKN3, and SKN2are shown in the Appendix.
SKN6 has smaller mse when compared with SKN2and SKN3
when the prior is close to the true potencycurve (d-,1) (see
Fig. 3.13).SKN6 is more efficient for d-,1; otherwise,SKN2
is more efficient.The SKN6 design will be compared with
the other methods for estimating ED50 when d-+1 insection
3.7; otherwise, SKN2 will be used.
3.4.1 Comparisons of Spearman-Kerber Method with Adaptive
Methods
SKN6 will be compared with B61,and SKNn will be
compared with Anm for n=2, 3.Comparing the r.e., SKN6 is
more efficient than the adaptive B61 designford-+1;
otherwise, A23 and A32 are more efficient thanthe SKN2 and
SKN3 designs respectively (see Fig. 3.14).
3.5 Up-and-down (Staircase) Method
The up-and-down method is another non-parametricmethod
for estimating ED50. The dose levelsare determined
sequentially.A series of test dose levels is chosen with
equal spacing between doses.The first level should be































negative response and decreasing the dose followinga
positive response.The estimated ED50 is Xf+kD, where Xf is
the last dose administered, k is a value from the provided
table (Dixon, 1965), and D is the interval between doses.
In this example, an experiment is conducted on six
subjects.We will choose x1=0.5, which is close to the true
ED50 for d close to 1.Since the true potency curve is
assumed to be P(x)=xd, d>0 and (:))cl, the D value (dose
interval) should be chosen in (0, .075) such that all doses
and ED50 lie in (0,1).Three values of De(.001,.035,
.075) are chosen in computing the exact distribution of the
ED50.For convenience ,we will adopt the following to
describe the experiments:
UDq :up-and-down method using cle(001, 035, 075)
as dose interval.
The fixed doses and the estimated ED50 of all possible
outcomes for UD001,UD035,and UD075 are shown in the
Appendix.
UD001 has smaller mse when compared with UD035 and
UD075 for d-41 (see Fig. 3.15).UD001 is more efficient for
d-41; otherwise, UD075 is more efficient.Since D is .001,
the fixed doses and estimated ED50 are all close to 0.5 for
all 64 outcomes.Also, UD001 is more efficient for d-)1, but
extremely less efficient for d#1. This extreme case,





























compare with other methods for estimating ED50 for d-41 in
section 3.7; otherwise, UD075 will be used.
3.5.1 Comparisons of Up-and-down Method with Adaptive
Methods
Comparing the r.e., UD035 is more efficient (UD075 is
less efficient) than the B61 design for d -+1, and UD035 and
UD075 are less efficient than the A23 and A32 designs for
d#1, but UD075 is more efficient than A23 and A32 designs
when d is extremely small (d<.003) or large (d>10) (see Fig.
3.16 ,...3.18).
3.6 Robbins-Monro Process
The Robbins-Monro stochastic approximationprocess is
used in sequential experiments to estimate the ED50.To
start the experiment, an initial guess xi is made at the
ED50, and n1 subjects are given the dose x1.If si subjects
have positive responses andpi=si/niisthe proportion
response, a second group of n2 subjects is tested at the
dose level x2=x1-c(p1 -.5). More generally, the dose level at




where c is a suitable chosen constant.
We will let x1=0.5 (the prior ED50) and choose c such
that all the tested doses and ED50 are in [0,1].The




























2, and 1 different experiments to be examinedby using the
Robbins-Monro process.The appropriate c values for the
different n1 are listed in Table 3.3.For convenience, we
will adopt the following to describethe experiments:
RMnCc : Robbins-Monro process forni=n and constant c
(see Table 3.3).
Table 3.3The values of c for n1=6, 3, 2, and1 such that
all the tested doses and ED50are in [0,1]
ni=6 ni=3 n1=2 ni=l
ce(0,1) cc(0,2/3) c(0,.5454) c(0,.4082)
The following examples of Robbins-Monromethods are used in
this section.




RM3C3 n.1 =3 c=.333
RM3C6 n.1 =3 c=.667
RM2C0 n1 =2c=.001
RM2C2 n1 =2 c=.25
RM2C5 n-=2c=.5454
RM1C0 n.1 =1c=.001
RM1C2 n1 =1 c=.2
RM1C4 n1 =1 c=.408
The fixed doses and estimated ED50 of allpossible outcomes
for the above examples are shown inthe Appendix.
Fig. 3.19 ~3.22 indicate thatRMnC0 for fixed n is
more efficient for d-,1 but extremely less efficientfor d#1,
and so is excluded from the comparisons.RM6C10 has the
smallest mse when compared with RM1C6,RM2C5, and RM3C6 for
d#1.RM2C2 has the smallest mse when compared withRM1C2,



























































four are similar.For RM1Cc designs, there are 6 fixed
doses sequentially chosen, making them more comparable with
adaptive designs.So, the RM1C2 will be compared with other
methodsforestimatingED50for d -+linsection3.7;
otherwise, RM6C10 and RM1C4 will be used for dill..
3.6.1 Comparison of Robbins-Monro Process with Adaptive
Methods
Comparing the RM6Cc method with the B61 design for d-41,
RM6Cc is more efficient for small c, but less efficient for
large c (see Fig. 3.23).Comparing RMnCc (n=2, 3) with the
Anm design for d4,1, RMnCc is less efficient than Anm design
for small c, but more efficient for large c (see Fig. 3.24,
3.25) .
Comparing the higher efficiency of the Robbins-Monro
method with adaptive designs, RM1C2 is more efficient than
B61 for d-,1, and RM6C10 and RM1C4 both are more efficient
than the A23 and A32 designs for d+1 (see Fig. 3.26).The
Robbins-Monro processis more efficient than adaptive
methodsin comparing the uniformly optimalcases with
respect to each method.
In the Robbins-Monro process and the previous up-and-
down method, estimation the ED50 depends on the initial
chosen dose, x1, and the constants, c and D.This results














































Fig. 3.25 The r.e. of A23/RM2Cc, c=.25, .5454
A23/RM2C2
A23/RM2C6
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The best designs for the adaptive methods have been
compared with non-adaptive, Spearman-Kdrber, up-and-down,
and Robbins-Monro methods in previous sections.Since the
complexities of comparing other methods with up-and-down and
Robbins-Monro methods are many, these comparisons will be
discussed in two parts.For d-,1, we would like to compare
{B61, NO61, SKN6, UD035, RM1C2).For d#1, we would like to
compare {A23, A32, NO16, SKN2, UD075, RM6C10, RM1C4).All
the comparisons are based on the r.e. of the chosen designs
relative to the NO16 design (see Fig. 3.32 and Fig. 3.37).
The individual r.e. plots of the chosen compared cases
for d-fl are shown in Fig. 3.27 UD035 and RM1C2 have
the highest efficiencies when d=1, but the efficiencies
decrease quickly (become lower efficiency) when d is shifted
from 1 (see Fig. 3.32).UD035 and RM1C2 have the steepest
curves, demonstrating more variability in their relative
efficiencies than the others.SKN6 and NO61 have higher
efficiencies than B61 for d-41 (see Fig. 3.32).
The individual r.e. plots of the chosen compared cases
for d#1 are shown in Fig. 3.33 Both RM6C10 and
RM1C4 dominate the other cases (see Fig. 3.37).Fig. 3.34
indicates that SKN2 is the least efficient when the prior
modal function is far away from the true model (d+1).The
r.e. of UD075 is less than 100% when dc(.08, .6)(see Fig.
3.36).UD075 is more efficient than A23 and A32 when d is







Fig. 3.27 The r.e. of
B61/N016
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Fig. 3.37 The r.e. of XX/N016, XX=A32, A23,
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A32 are more efficient (see Fig. 3.37).Since the Spearman-
Kdrber and non-adaptive methods are less efficient for d41,
and the Robbins-Monro and up-and-down methods demonstrate
more variability in estimating the ED50,the adaptive
designs A23 and A32 are more consistently efficient.
The Spearman-Kdrber estimator, Robbins-Monro process,
and up-and-down method are designed for estimating the ED50.
They cannot be used to estimate the potency curves.The
adaptive designs cannot only be used to estimate the ED50,
but also can be used to estimate the potency curves.70
4 NORMAL APPROXIMATION METHOD TO ESTIMATE THE ORDER OF THE
AUTOREGRESSIVE (AR) MODEL UNDER BAYESIAN POINT OF VIEW
4.1 The Bayesian Approach to Order Estimation of AR Process
Let v. be the prior probability that the order of a
stationarity autoregressive time series is j (j=0,1,...,M)
such that E vi=1, where M is the maximum order of the AR
model. Let Xn:=(Xl, Xn) 'be a vector of n consecutive
observations and90e=(91,...,9m)bea vector of partial
autocorrelations,from a stationary AR(p)model with p

















6() is the Dirac delta function and Km(%) is defined as
(1.37).
From (4.1), Robb (1980) expressed the marginal posterior
probability density of the order given the data aswhere
ff
1 1
4, (in,'Pm) cl(Pm chpi
(2En, k, (pm) dcpmciv1
k=01
n+3
r i (1-4)1)Ki ( gi) 2chpichpi
n+3









The Bayes estimator is used to minimize theBayes risk
withrespecttothelossfunction. Robb chosethe
particular loss function as:
L(0, a) = 0 if e=a (decision is correct)
= 1otherwise (decision is wrong) . (4.5)
The Bayes risk is defined by
R(0, 8) = E( L(0,8(2))]=f F(8,1)dlix
where
F (a, I )=feL(e,a) f(.7f, 0) do (0) .
(4.6)
(4.7)
f(X,O)is the density of X given 0,v(0)is the prior
probability distribution for 0, andx and 6 are the domain72
of X and 0,respectively.So, R(0,6)is minimized by
minimizing F(6(8), X).In the present case, we have






= E 1k krj (4.8)
for some je(0, 1,..., M).If j is chosen to be the integer
between 0 and M such that I.is a maximum, the function
F(j,8n) is minimized and j should bea Bayes estimator of
the order p. Robb derived the approximated posterior
probability of the order given data to simplifythe multiple
integration in (4.4).And Robb wrote (4.3) as
Itpir(i lira)
1 i+1







where (ei is the approximated mle ofp1.
One way to deal with the multiple integrations in (4.3)
is to use the closed Newton-Cotes integrationformulas
(Burden (1981)) to approximate Ij in (4.4).The boundary of
the closed Newton-Cotes formulasisin(-1,1]. The
quadrature formula for Newton-Cotes is givenasEf (x) dx z Eci f (xi)
73
(4.10)
where Ci and xi (1=1, N) are the weight coefficients and
the roots of the function, respectively.In (Burden, 1981),
we can find the corresponding Ci and x. for N up to 5.With
Newton-Cotes closed formula, we have
/k = 7C k2-k E
ii=0
N






for k=1,..., M.In general, the answer is accurate enough
if N=3 because the degree of precision is up to (2N-1) for
Newton-Cotes closed formula.To deal with the multiple
summations is still a big problem because we have torun Nk
iterations to get the final answer and Kk(tpk)is difficult
to calculate.It takes a very long time to get the answer
if k is large even with modern computers.In the following
section the normal approximation method will be applied
again to solve the computation problem mentioned above.
4.2Normal Approximation Approach
The marginal probability density of order p given the
data is shown as (4.3).TheIkin (4.4) can be expressed as
irIk= ji. ilfk(fpk)k 4 1
where
(4.12)-(n+3)




To apply the normal approximation we will approximate fk(9k)
by a constantCkmultiplied the multivariate normal density





cand covariance E* and express
k -1
1 Ck(±)71E* I2-exp{--2(,,*) Es"(9-9*)1
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Substitute 9* into (4.14) and get
k _1
fk(11)*) C k (+;)E* I2

















Ck mvN(Ipk; "% Es) dpk d(pi.
=Ck
(4.19)
The multiple integrations of Ik has been simplified and









kis given in (4.18).However, and E* are needed
before approximating Ik by Ck.The Newton-Raphson method is
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21(k(f p oc) ij .
(4.22)
In order to obtain the first and second derivative of Kk(tpk)76
with respect to we we need to express all of the functions
of 9k in terms of O's.From (1.34) and (1.37), we have
Kk (41k) = Hk (0k)
1,kDke1,k
Applying chain rule we obtain







Dk*is same asDkwithout the first row and 01,k= (1,0k,1
ek,k) The expressions Oksi (j=1, k) in terms of 9
is shown in (1.32), i.e.,
ek,k =Ok
0 0k-1, j fk°k-1,k-j (j=1, k-1)



















Differentiate (4.24) and (4.25) and geta2 ) alEkr * L2/21,01, ki + [2D* * c#3° 414; aoia9i k

















Similarly, we can express each element in
a2ek-1,m a20k-1,k-m_a2ek,n,




for m=1,..., k-1 and
"" 0 (i,j =1,..., 424,
for m=k.Let
9 = (91, cd
u






The mode 9* can be found by using Newton-Raphson method
shown as
(pro = yr - U(4r) de (yr) (4.37)
for (r+1)
toiteration.From (1.43) we can evaluate the least78
square estimates 13*=(0p1*.. .,0 *)which will be used to
choose the initial value of cp,i.e.,
0* = [D "Yid (p=1, k) (4.38)
*
1.4 =((Qi, (4) Ir =0 =
In
u1,1 ekA) (4.39)
If the sequence converges, say, to 9*, then (1)*=((p1 *, ,ck*)
is the mode.Substituting e* into (4.22), we can solve for
E*, i.e.,
E* = d0) -11 (4.40)
according to (4.16) and (4.25).Once we obtain 9* and E*,
C
kcan be calculated from (4.13) and (4.18), i.e.,
{k
i -(n+3) k 1
Ck = IC k2-Ic IT(1-(C)2)2Kk(r) 2(270 21E4.12
i=0 (4.41)
4.3Examples for Wolfer's Sunspot data
Wolfer's sunspot data consists monthly means of daily
relative sunspot number which are based upon counts of spots
and groups of spots beginning in 1749.The yearly means of
sunspot data observed in 176 consecutive years which can be
found in most of time series analysis books.The most
currentdataiscollectedbytheTokyoAstronomical
observatory from 1749 to 1977.We transform the data by
taking square root of this sunspots data from 1749 to 1924
corrected for the mean.The following methods will be used
to comparing each other.Akaike's future prediction error
(FPE) and information criterion (AIC), Schwarz's Bayesian
informationcriterion (BIC)andHannanandQuinn's79
information criterion (CIC), Robb'sBayes estimation of the
order and the Bayesian normal approachall choose a maximum
order M=15 to estimate the order ofAR time series.For
Robb's Bayes estimator of order andthe Bayesian normal
approach, let /7)=1/16, j=0,1,..., 15 and
function as (4.5).The estimation criteria
list as following.
=n +j+1R FPE(p) =min/FPE(j) j= 0,
define the loss







AIC(p) = minIAIC(j) =1nRi + 2jI j = 0, n








1..;= 0, 3., ..., m M
E1k
k=0




J(1.44) is the role of the variance a2from a model
with j parameters estimated and rpfx(jiXn) are estimated by
(4.9) and Cj can be calculated from(4.41).
The estimation results of analyzingthe transformed
sunspot data from these methods is givenin Table 4.1.
Akaike's FPE and AIC both have the absoluteminimum value at80
the 9th order but Schwarz's BIC, Hannan and Quinn's CIC and
Robb's and the Bayesian normal approach all have thesame
estimated order at the2ndorder,which means all the
consistent estimators for order yield thesame results.The
asymptotic results of Schwarz Bayesian criterion do not
depend on the prior distribution and our Bayesian normal
approach has the same results as Schwarz's BIC results and
both put very large weights on the 2nd and 3"1 orders.
The closed Newton-Cotes method mentioned in section 4.1
is very accurate, but the running time isvery much.It is
good to compare this method with the normal approximation
method for M=12 and n=3.The results is shown in Table 4.2
Both methods have thesameresultsthat the maximum
posterior probability of the order is at j=2.However, the
running time of the normal approximation approach is much
less than the Newton-Cotes method.
Consider the most current sunspot data collected from
1749 to 1977.By using FPE, AIC, BIC, CIC, and Bayesian
normal approach to analyze the mean corrected square root of
the yearly averages (the maximum order M=15), the results is
shown in Table 4.3 and plot of the data is given in Fig.
4.1.The best fitted AR model is the 9th order for the most
current transformed sunspots data for all criteria.
FPE,AIC,BIC,and CIC do not give full posterior
results, but the Robb's and normal approximation approach
do.81
Table 4.1The results of analyzing Wolfer's sunspot data
for 1749-1924 using FPE, AIC, BIC, CIC, Robb, and
normal approximation metnoa ror rne oraer p





0 5.35651.6669 1.66691.6669.0000 .0000
1 1.79050.57110.58910.5784.0000 .0000
2 1.03950.0273 0.0633*0.0419*.7677^ .6678^
3 1.03830.0262 0.08020.0481 .2070 .2793
4 1.04960.03700.10910.0663 .0204 .0272
5 1.05840.04540.13540.0819 .0024 .0042
6 1.05350.04070.14870.0845.0008 .0018
7 1.03710.02490.15110.0761.0008 .0053
8 1.02950.0177 0.16180.0761 .0000 .0023
9 1.0115*0.0000*0.16210.0658 .0000 .0107






'A': indicates that the value is maximum.
'*': indicates that the value is minimum.82
Table 4.2The results of analyzing Wolfer's sunspot data
for 1749-1924 from the closed Newton-Cotes (N=3)
and Bayesian normal approximation method for
choosing the maximum order M=12














'*': indicates that the value ismaximum.83
Table 4.3The results of analyzing Wolfer's sunspot data
for 1749-1977 using FPE, AIC, BIC, CIC, and
normal approximation method for the order p
assumed the maximum order M=15
j FPE.
J
. AICJ BICJ . CIC.
J 701E01 Xn)
0 6.3096 1.8333 1.8333 1.8333 0.0000
1 2.0921 0.7294 0.7444 0.7355 0.0000
2 1.1353 0.1182 0.1482 0.1303 0.0022
3 1.1308 0.1142 0.1592 0.1324 0.0009
4 1.1408 0.1229 0.1829 0.1471 0.0000
5 1.1440 0.1258 0.2008 0.1561 0.0000
6 1.1109 0.0964 0.1864 0.1327 0.0000
7 1.0879 0.0755 0.1804 0.1178 0.0006
8 1.0634 0.0526 0.1726 0.1011 0.0011
9 1.0088* 0.0000* 0.1349* 0.0544* 0.9109
.,
101.0173 0.0084 0.1583 0.0689 0.0769
111.0261 0.0169 0.1819 0.0835 0.0066
121.0349 0.0255 0.2054 0.0980 0.0006
131.0439 0.0341 0.2290 0.1127 0.0000
141.0392 0.0295 0.2394 0.1142 0.0000
151.0479 0.0378 0.2627 0.1285 0.0000
'A': indicates that the value is maximum.
'*': indicates that the value is minimum.Fig. 4.1 Meancorrected of the square root of yearly
averages of sunspots data 1749-1977
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5CONCLUSIONS
In Bayesian analysis, means are commonlyused to
summarize Bayesian posterior distributions.Problems with
a large number of parameters,often require numerical
integrations over many dimensions to obtainmeans.In this
dissertation, posterior modes withrespect to appropriate
measureswereusedtosummarizeBayesianposterior
distributions.Two statistical estimation problemswere
investigated here. These were the sequentialdose selection
inbioassay,andtheselectionoftheorderofan
autoregressive model.
First, for Bayesian bioassay, two adaptivedesigns were
developed for sequential dose selectionto estimate the
potency curve by using posterior modes.The first was a
full information method employing thefull likelihood for
all collected doses and usinga full prior distribution to
obtain modes and estimate the potencycurve.The second was
thereducedinformationmethodforsimplifyingthe
complexity of the full information method.In this second
procedure, the Dirichlet prior was modifiedby updating the
prior parameters in each step.Modes were obtained at
experimental doses in each step,so the full modal potency
curve was determined according to these modes andthe
previously estimated potencycurve.
The relative efficiencies of the adaptive designsfor
estimating theED50were compared. For prior guess86
functionsclosetothetruefunction,thereduced
information method involving assignment of subjects to doses
close to the ED50,is more efficient.For prior guess
functions which are not close to the true function, the full
information method of choosing nearly equal numbers of doses
and steps is more efficient.
A comparison of the relative efficiencies of the
adaptive designs with other non-Bayesian methods (Spearman-
Karber, up-and-down, and Robbins-Monro) shows that the full
information is appropriate for estimating the ED50 when the
prior guess function is not close to the true function.The
reduced information method is less efficient than other
methods for estimating the ED50 when the priorguess is
close to the true function. These non-Bayesian methodswere
designed for estimating the ED50 only, while the adaptive
designs were designed for estimating both theED50 and the
potency curve.
Second, determination of the order of an autoregressive
model following Robb's method(1980)by evaluating the
marginalposteriorprobabilitiesoftheorderwas
considered.The normal approximation method was used to
approximate a function in the posterior density such that
theintegrationsovermanydimensionsproblemwas
simplified.This method was compared with other methods
(FPE, AIC, BIC, and CIC) by choosing Wolfer's sunspot data
an example. FPE,AIC,BIC,and CIC were developed to87
estimate the order of an autoregressive model.In contrast
to Robb's method and the normal approximation approach,
these methods do not give full posterior results.All the
Bayesian methods(Robb's,BIC,and normal approximation
approach) have the same estimated order.
For further inference, approximateposterior
distributions can be based on the multivariate normal
distribution.88
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The fixed doses and the estimated ED50 for64 possible
outcomes when L=6 (L=m*n) for Anm and Bnm designs.
Al6=B16




































































































































































































S >C1 >C2 >C3 )C4 C 5 x6 E r) 5 0
0 00 0.500000.625000.714290.783060.837270.880090.91354 0 01 0.500000.625000.714290.783060.837270.880090.85127 0 10 0.500000.625000.714290.783060.837270.800760.81595 0 11 0.500000.625000.714290.783060.837270.800760.78813 1 00 0.500000.625000.714290.783060.736990.757370.77029 1 01 0.500000.625000.714290.783060.736990.757370.74457
110 0.500000.625000.714290.783060.736990.720440.72736 1 11 0.500000.625000.714290.783060.736990.720440.71568 0 00 0.500000.625000.714290.655370.683730.700790.70914 0 01 0.500000.625000.714290.655370.683730.700790.69100 0 10 0.500000.625000.714290.655370.683730.666270.67450 0 11 0.500000.625000.714290.655370.683730.666270.65903 1 00 0.500000.625000.714290.655370.632570.642870.64942 1 01 0.500000.625000.714290.655370.632570.642870.63649
110 0.500000.625000.714290.655370.632570.626350.62885
111 0.500000.625000.714290.655370.632570.626350.62520 0 00 0.500000.625000.545930.588560.612000.621500.62424 0 01 0.500000.625000.545930.588560.612000.621500.61672 0 10 0.500000.625000.545930.588560.612000.599100.60589 0 11 0.500000.625000.545930.588560.612000.599100.59266 1 00 0.500000.625000.545930.588560.563290.576330.58332 1 01 0.500000.625000.545930.588560.563290.576330.56900
110 0.500000.625000.545930.588560.563290.551850.55723
111 0.500000.625000.545930.588560.563290.551850.54768 0 00 0.500000.625000.545930.509930.528460.538940.54349 0 01 0.500000.625000.545930.509930.528460.538940.53348 0 10 0.500000.625000.545930.509930.528460.517580.52310 0 11 0.500000.625000.545930.509930.528460.517580.51271 1 00 0.500000.625000.545930.509930.500500.504750.50757 1 01 0.500000.625000.545930.509930.500500.504750.50212
110 0.500000.625000.545930.509930.500500.500000.50019
111 0.500000.625000.545930.509930.500500.500000.50000 0 00 0.500000.375000.454070.490070.499500.500000.50000 0 01 0.500000.375000.454070.490070.499500.500000.49981 0 10 0.500000.375000.454070.490070.499500.495250.49788 0 11 0.500000.375000.454070.490070.499500.495250.49243 1 00 0.500000.375000.454070.490070.471540.482420.48729 1 01 0.500000.375000.454070.490070.471540.482420.47690 1 10 0.500000.375000.454070.490070.471540.461060.46652
111 0.500000.375000.454070.490070.471540.461060.45651 0 00 0.500000.375000.454070.411440.436710.448150.45232 0 01 0.500000.375000.454070.411440.436710.448150.44277 0 10 0.500000.375000.454070.411440.436710.423670.43100 0 11 0.500000.375000.454070.411440.436710.423670.41668 1 00 0.500000.375000.454070.411440.388000.400900.40734 1 01 0.500000.375000.454070.411440.388000.400900.39411 1 10 0.500000.375000.454070.411440.388000.378500.38328
111 0.500000.375000.454070.411440.388000.378500.37576 0 00 0.500000.375000.285710.344630.367430.373650.37480 0 01 0.500000.375000.285710.344630.367430.373650.37115 0 10 0.500000.375000.285710.344630.367430.357130.36351 0 11 0.500000.375000.285710.344630.367430.357130.35058 1 00 0.500000.375000.285710.344630.316270.333730.34097 1 01 0.500000.375000.285710.344630.316270.333730.32550
1 10 0.500000.375000.285710.344630.316270.299210.30900
111 0.500000.375000.285710.344630.316270.299210.29086 0 00 0.500000.375000.285710.216940.263010.279560.28432 0 01 0.500000.375000.285710.216940.263010.279560.27264 0 10 0.500000.375000.285710.216940.263010.242630.25543 0 11 0.500000.375000.285710.216940.263010.242630.22971 1 00 0.500000.375000.285710.216940.162730.199240.21187 1 01 0.500000.375000.285710.216940.162730.199240.18405
110 0.500000.375000.285710.216940.162730.119910.14873 1 11 0.500000.375000.285710.216940.162730.119910.08646
95B23
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The fixed doses (xj=3./(m+1), i=1,...,n) and the estimated




























































The fixed doses(x1 =i/(m+1), i=1,...,n) and the estimated
ED50 for SKNn (n=2,3,6) designs when L=6 (L=m*n) .
SKN2























































The fixed doses and estimated ED50 for 64 possible outcomes
when L=6 for UDq (q=001) design.
UD001

































































The fixed doses and estimated ED50 for 64 possibleoutcomes
when L=6 for UDq (q=035) design.
UD035
S X1 X2 X3 x4 x5 x6ED50























































The fixed doses and estimated ED50 for 64 possible outcomes
when L=6 for UDq (q=075) design.
UD075

































































The fixed doses and estimated ED50 for 64 possible outcomes
when L=6 for RM1Cc (n=1, c=.001) design.
RM1C0

































































The fixed doses and estimated ED50 for 64 possible outcomes
when L=6 for RM1Cc (n=1, c=.2) design.
RM1C2

































































The fixed doses and estimated ED50 for 64 possible outcomes
when L=6 for RM1Cc (n=1, c=.408) design.
RM1C4

































































The fixed doses and estimated ED50 when L=6 for RM2Cc (n=2,
c=.001,.25) designs.
RM2C0

























































The fixed doses and estimated ED50 when L=6for RM2Cc (n=2,
c=.5454) design.
RM2C5
X1 x2 x3 ED50
0 00 0.500000.772730.909091.00000 0 01 0.500000.772730.909090.90909 0 02 0.500000.772730.909090.81818 0 10 0.500000.772730.772730.86364 0 11 0.500000.772730.772730.77273
012 0.500000.772730.772730.68182
0 20 0.500000.772730.636360.72727
0 21 0.500000.772730.636360.63636 0 22 0.500000.772730.636360.54545












2 21 0.500000.227270.090910.09091 2 22 0.500000.227270.090910.00000109
























































The fixed doses and estimated ED50 when L=6 for RM6Cc (n=6,
c=.001,.5,1) designs.
RM6C0
s xlED50
O 0.50000 0.50050
1 0.50000 0.50033
2 0.50000 0.50017
3 0.50000 0.50000
4 0.50000 0.49983
5 0.50000 0.49967
6 0.50000 0.49950
RM6C5
xlED50
O 0.50000 0.75000
1 0.50000 0.66667
2 0.50000 0.58333
3 0.50000 0.50000
4 0.50000 0.41667
5 0.50000 0.33333
6 0.50000 0.25000
RM6C10
s xlED50
O 0.50000 1.00000
1 0.50000 0.83333
2 0.50000 0.66667
3 0.50000 0.50000
4 0.50000 0.33333
5 0.50000 0.16667
6 0.50000 0.00000